Zimbabwe has declined a significant US health deal valued at $367m (£272m) over five years because of the United States' demand for sensitive biological samples.
This move became public following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative later clarified that the United States was seeking biological samples for scientific study and commercial purposes but refused to guarantee the resulting advantages from any future treatments.
"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for more dialogue to secure a agreement agreeable to both sides so the country's vital HIV programme can proceed.
Wider Implications
This development comes after a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement following concerns were filed about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to boost transparency and accountability.
Based on reports, Sixteen nations in Africa have to date signed similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.
"Put simply, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be available to our people if a new health crisis arise."
National Interest and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining systems already established through the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
These objections regarding the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration might be arranged in a manner that honours the independence and interests of both nations."
Health Experts Response
A leading public health body expressed it understood the official position, but suggested that negotiations must proceed considering much of the country's HIV programmes were funded by external financing.
"Where technical issues exist, including those relating to data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
The halted deal underscores the complex tensions between receiving crucial foreign assistance and safeguarding local interests in an increasingly interconnected world.